Interview with Jean LE LOUS, President and Chief Executive Officer of FOURNIER Laboratories about the authoritarian price cut of 250 drugs decided by the government. Jean LE LOUS discusses the savings measures that this reduction will bring and in particular the reduction of research costs.
Producteur: France Régions 3 Dijon - Journalist : Pannard, Christian - Journalist : Garnier, Michel - Photo Journalist : Palasse, Jean Pierre - Participant : Le Lous, Jean
Origin:
Jt Fr3 Burgundy - Producteur: France Régions 3 Dijon
Licence:
Turnkey
×
Mediaclip turnkey licences
Accessible rights for all uses, in the whole world, in accordance with our T&Cs.
Digital Publication : use for editorial publications - to inform the general public or illustrate the news - for digital broadcast on services, valid for 5 years.
Corporate/Brand content : use for the presentation and promotion of an image, brand, history and values of the Contracting Partner company - or, where applicable, the Beneficiary - for digital broadcast on its services and/or for Events, valid for 1 year.
Cultural Licence : use for cultural purposes and restricted to members of the cultural network. Digital publication for a term of 5 (years) and Events for a term of 1 (one) year from the order payment date.
Reference:R23174026
Credits:Journalist : Pannard, Christian-Journalist : Garnier, Michel-Photo Journalist : Palasse, Jean Pierre-Participant : Le Lous, Jean